Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-05-13
1990-09-04
Rivers, Diana G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514261, 514262, 514266, 544276, 544277, A61K 3152, C07D47318, C07D47334
Patent
active
049545043
ABSTRACT:
The compound of the formula I ##STR1## wherein R, R.sub.3 and R.sub.5 independently represent hydrogen or hydroxy provided that at least one of R, R.sub.3 and R.sub.5 represents hydroxy; R.sub.1 represents hydrogen, lower alkyl, C.sub.3 -C.sub.7 -alkenyl, hydroxy-lower alkyl, optionally substituted cycloalkyl or optionally substituted cycloalkyl-lower alkyl, bicycloalkyl, bicycloalkyl-lower alkyl, adamantyl, tetrahydropyranyl, tetrahydrothiopyranyl, tetrahydropyranyl-lower alkyl, tetrahydrothiopyranyl-lower alkyl, adamantyl-lower alkyl, aryl-hydroxy-lower alkyl, aryl, aryl-lower alkyl, aryl-C.sub.3 -C.sub.6 -cycloalkyl, 9-fluorenyl, 9-fluorenyl-lower alkyl or cycloalkenyl-lower alkyl; or R.sub.1 represents a bicyclic benzo-fused 5 or 6-membered saturated cyabocyclic radical or a benzo-fused 5 or 6-membered saturated heterocyclic radical containing a heteroatom selected from oxygen and sulfur directly attached to the fused benzene ring, any said bicyclic radicals being optionally substituted on the benzo portion by lower alkyl, lower alkoxy or halogen, or R.sub.1 represents any said bicyclic radical substituted-lower alkyl; R.sub.2 represents hydrogen, halogen, --S--R.sub.1 ', --NR.sub.b --R.sub.1 ', or --NH--R.sub.1 ' in each of which R.sub.1 ' has meaning as defined for R.sub.1 provided that R.sub.1 ' in --SR.sub.1 ' does not represent hydrogen; R.sub.b represents lower alkyl; R.sub.4 represents hydroxymethyl provided that R.sub.2 does not represent either hydrogen or --NHR.sub.1 ' in which R.sub.1 ' represents either hydrogen or lower alkyl; or R.sub.4 represents lower alkoxymethyl or lower alkylthiomethyl; or R.sub.4 represents --CONHR.sub.6 in which R.sub.6 represents lower alkyl; aryl-lower alkyl, C.sub.3 -C.sub.6 -cycloalkyl or hydroxy-lower alkyl; pharmaceutically acceptable ester derivatives thereof in which free hydroxy groups are esterified in form of a pharmaceutically acceptable ester; and pharmaceutically acceptable salts thereof; methods for their preparation; and their use as adenosine receptor agonists are disclosed.
REFERENCES:
patent: 3590029 (1971-06-01), Koch et al.
patent: 3752805 (1973-08-01), Maguire et al.
patent: 3825541 (1974-07-01), Vince
patent: 3838147 (1974-09-01), Pohlke et al.
patent: 3936439 (1976-02-01), Marumoto et al.
patent: 3968102 (1976-06-01), Suchiro et al.
patent: 3992531 (1976-11-01), Prasad et al.
patent: 4029884 (1977-06-01), Stein et al.
patent: 4104462 (1978-08-01), Fischer et al.
patent: 4138562 (1979-02-01), Vince
patent: 4167565 (1979-04-01), Stein et al.
patent: 4255565 (1981-03-01), Marumoto et al.
patent: 4258033 (1981-03-01), Marumoto et al.
patent: 4268672 (1981-05-01), Vince
patent: 4293690 (1981-10-01), Sawa et al.
patent: 4338310 (1982-07-01), Vince
patent: 4341769 (1982-07-01), Marumoto et al.
patent: 4362729 (1982-12-01), Vince
patent: 4383114 (1983-05-01), Vince
patent: 4501735 (1985-02-01), Trivedi et al.
patent: 4543255 (1985-10-01), Shealy et al.
patent: 4593019 (1986-06-01), Bristol et al.
patent: 4594350 (1986-06-01), Vince
patent: 4600707 (1986-07-01), Patt
patent: 4683223 (1987-07-01), Trivedi
patent: 4728736 (1988-01-01), Shealy et al.
patent: 4728736 (1988-03-01), Shealy et al.
patent: 4740598 (1988-04-01), Nagabhushan et al.
patent: 4742064 (1988-05-01), Vince
Coward, et al., Chemical Abstracts, vol. 79:87815x (1973).
Vince, Chemical Abstracts, vol. 96:181575s (1982).
Borchardt, et al., Chemical Abstracts, vol. 84:53773v (1976).
Miyashita, et al., Chemical Abstracts, vol. 106:84996x (1987) abstract of Japan 85/215,685, 10/29/85.
Marquez, et al., "Carbocyclic Nuceosides, Medicinal Research Reviews", vol. 6, No. 1, pp. 1-8, 11, 13-18, 37-40.
J. Org. Chem., vol. 51, pp. 1287-1982 (1986) Madhasuau, et al.
Shealy, et al., J. Am. Chem., vol. 91, p. 3075 (1969).
Herdewija, et al., J. Med. Chem., vol. 28, p. 1385 (1985).
Shealy, et al., J. Med. Chem., vol. 27, pp. 670-674 (1984).
Cormack et al., Tetrahedron Letters, vol. 1981, p. 2331 (1981).
Vince, et al., J. Org. Chem., vol. 45, p. 531 (1980).
Paulsen, et al., Chem. Ber., vol. 114, p. 346 (1981).
Marumoto, et al., Chem. Pharm. Bull., vol. 24, p. 2624 (1976).
J. Pharmacology and Experimental Therapeutics, vol. 238, p. 954 (1986).
Marumoto et al., Chem. Abstracts 105:126814y (1986).
Marumoto, et al., Chem. Pharm. Bull., vol. 23, p. 758 (1975).
Daly, et al., Biochemical Pharmacology, vol. 35, p. 2467 (1986).
Moos, et al., J. Med., vol. 28, p. 1383 (1985).
Asahi Chemical Industry, Chem. Abstracts vol. 94:140119m (1981).
Kikugawa, et al., Chem. Abstract vol. 84:31369r (1976).
Kikugawa, et al., Chem. Abstr. vol. 84:74578a (1976).
Chem. Abstr. vol. 85:177889c (1976).
Montgomery et al., Biol. Methylation Drug Res. (Proc. Symp. 1985) pp. 409-416 (1986).
Lizotte, et al., Chem. Abstr. 99:139657g (1983).
Michelich, et al., Chem. Abstr. 98:125739c (1983).
Omura, et al., Chem. Pharm. Bull., vol. 29, No. 7, pp. 1870-1875 (1981).
Hamilton, et al., Life Sciences, vol. 41, pp. 2295-2302 (1987).
Marumoto, et al., Chem. Pharma. Bull., vol. 23, pp. 759-774 (1975).
Marumoto, et al., Takeda Res. Labs., vol. 44, pp. 220-230 (1985).
CA 84:74378a (1976), Kikugawa, et al.
R. N. Prasad et al., J. Med. Chem., vol. 23, pp. 313-319 (1980).
R. F. Bruns, Can. J. Physio. Pharmacol., vol. 58, pp. 673-691 (1980).
Chen Jen
Hutchison Alan J.
Ciba-Geigy Corporation
Gruenfeld Norbert
Rivers Diana G.
LandOfFree
N.sub.9 -cyclopentyl-substituted adenine derivatives having aden does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N.sub.9 -cyclopentyl-substituted adenine derivatives having aden, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N.sub.9 -cyclopentyl-substituted adenine derivatives having aden will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-442255